| Literature DB >> 19729843 |
James M Musser1, Samuel A Shelburne.
Abstract
Molecular pathogenomic analysis of the human bacterial pathogen group A Streptococcus has been conducted for a decade. Much has been learned as a consequence of the confluence of low-cost DNA sequencing, microarray technology, high-throughput proteomics, and enhanced bioinformatics. These technical advances, coupled with the availability of unique bacterial strain collections, have facilitated a systems biology investigative strategy designed to enhance and accelerate our understanding of disease processes. Here, we provide examples of the progress made by exploiting an integrated genome-wide research platform to gain new insight into molecular pathogenesis. The studies have provided many new avenues for basic and translational research.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19729843 PMCID: PMC2735924 DOI: 10.1172/JCI38095
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808